Clinical Transplantation

Article	Citations
Incidence, risk factors, treatment, and consequences of antibody‐mediated kidney transplant rejection: A systematic review	48
Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in the United States	44
SARS‐COV‐2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications	43
Pig kidney xenotransplantation: Progress toward clinical trials	38
Early United States experience with liver donation after circulatory determination of death using thoraco‐abdominal normothermic regional perfusion: A multi‐institutional observational study	37
Intraoperative transfusion management, antifibrinolytic therapy, coagulation monitoring and the impact on short‐term outcomes after liver transplantation—A systematic review of the literature and expe	36
Excess mortality in solid organ transplant recipients hospitalized with COVID‐19: A large‐scale comparison of SOT recipients hospitalized with or without COVID‐19	36
Bamlanivimab for treatment of COVID‐19 in solid organ transplant recipients: Early single‐center experience	33
Does liver biopsy accurately measure fibrosis in Fontan‐associated liver disease? A comparison of liver biopsy pre–combined heart and liver transplant and liver explant post‐transplant	32
State‐of‐the‐art machine learning algorithms for the prediction of outcomes after contemporary heart transplantation: Results from the UNOS database	30
Enhanced recovery after surgery programs improve short‐term outcomes after liver transplantation–A systematic review and meta‐analysis	27
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS‐CoV‐2 vaccine	27
Evolving utilization of donation after circulatory death livers in liver transplantation: The day of DCD has come	27
Does machine perfusion improve immediate and short‐term outcomes by enhancing graft function and recipient recovery after liver transplantation? A systematic review of the literature, meta‐analysis an	27
Transplant outcomes using kidneys from high KDPI acute kidney injury donors	24
Impact of heart transplant allocation change on competing waitlist outcomes among listing strategies	23
The changing landscape of pediatric lung transplantation	21
Donor‐derived cell‐free DNA is associated with cardiac allograft vasculopathy	21
Perioperative fluid management and outcomes in adult deceased donor liver transplantation – A systematic review of the literature and expert panel recommendations	21
Removal of the Black race coefficient from the estimated glomerular filtration equation improves transplant eligibility for Black patients at a single center	20
Impact of pre‐transplant carbapenem‐resistant Enterobacterales colonization and/or infection on solid organ transplant outcomes	20
Using race to estimate glomerular filtration and its impact in kidney transplantation	20
Gut microbiota profiles and fecal beta‐glucuronidase activity in kidney transplant recipients with and without post‐transplant diarrhea	20
COVID‐19 in hospitalized liver transplant recipients: An early systematic review and meta‐analysis	20
What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? A systematic review of the literature and expert panel recommendations	19

Extracorporeal photopheresis and its role in heart transplant rejection: prophylaxis and treatment	18
Pediatric lung transplantation as standard of care	17
Abdominal wall complications after kidney transplantation: A clinical review	17
Does modification of portal pressure and flow enhance recovery of the recipient after living donor liver transplantation? A systematic review of literature and expert panel recommendations	17
Lung transplantation for the treatment of irreversible acute respiratory distress syndrome	17
eHealth literacy and web‐based patient portal usage among kidney and liver transplant recipients	16
Prevalence and characterization of frailty, depression, and cognitive impairment in patients listed for heart transplantation: Results of the FELICITAR prospective registry	16
Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID‐19)	16
Transplantation of kidneys after normothermic perfusion: A single center experience	15
Wait expectations: The impact of delisting as an outcome from the kidney transplant waitlist	15
Acute kidney injury post‐heart transplant: An analysis of peri‐operative risk factors	15
Hyperammonemia syndrome associated with Ureaplasma spp. Infections in immunocompromised patients and transplant recipients: A systematic review and meta‐analysis	15
Sodium‐glucose cotransporter 2 inhibitors for treatment of diabetes mellitus after kidney transplantation	15
Nitazoxanide treatment for norovirus infection in solid organ transplant recipients	15
Normothermic with or without hypothermic oxygenated perfusion for DCD before liver transplantation: European multicentric experience	15
Operational challenges in the COVID‐19 era: Asymptomatic infections and vaccination timing	15
Magnetic resonance imaging‐derived proton density fat fraction (MRI‐PDFF) is a viable alternative to liver biopsy for steatosis quantification in living liver donor transplantation	15
The type of SARS‐CoV‐2 vaccine influences serological response in kidney transplant recipients	15
The impact of the SARS‐CoV‐2 pandemic and COVID‐19 on lung transplantation in the UK: Lessons learned from the first wave	14
Sex and gender disparity in kidney transplantation: Historical and future perspectives	14
Association of race and gender with primary caregiver relationships and eligibility for advanced heart failure therapies	14
Impact of the United Network for organ sharing 2018 donor heart allocation system on transplant morbidity and mortality	14
Impact of the duration of normothermic regional perfusion on the results of liver transplant from controlled circulatory death donors: A retrospective, multicentric study	14
Left‐digit bias and deceased donor kidney utilization	14
Kidney allograft rejection: Diagnosis and treatment practices in USA‐ A UNOS survey	14
Decreased frequency of transplantation and lower post‐transplant survival free of re‐transplantation in LVAD patients with the new heart transplant allocation system	13
Renal transplantation during the SARS‐CoV‐2 pandemic in the UK: Experience from a large‐volume center	13
Impact of UNOS allocation policy changes on utilization and outcomes of patients bridged to heart transplant with intra‐aortic balloon pump	13
SARS‐CoV‐2 infection increases tacrolimus concentrations in solid‐organ transplant recipients	13
Adult liver transplant anesthesiology practice patterns and resource utilization in the United States: Survey results from the society for the advancement of transplant anesthesia	13
Infectious complications in allogeneic hematopoietic cell transplant recipients: Review of transplant‐related risk factors and current state of prophylaxis	13
Immune response to third SARS‐CoV‐2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction	13
What is the optimal anesthetic monitoring regarding immediate and short‐term outcomes after liver transplantation?—A systematic review of the literature and expert panel recommendations	13
Mobile health technology to improve emergent frailty after lung transplantation	13
Letermovir treatment for CMV infection in kidney and pancreas transplantation: A valuable option for complicated cases	13
The role of prehabilitation on short‐term outcomes after liver transplantation: A review of the literature and expert panel recommendations	13
Meta‐analysis and systematic review: Prevalence, graft failure, mortality, and post‐operative thrombosis in liver transplant recipients with pre‐operative portal vein thrombosis	13
The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemia	12
ProtekDuo as a bridge to lung transplant and heart‐lung transplant	12
Variations in deceased donor kidney procurement biopsy practice patterns: A survey of U.S. organ procurement organizations	12
Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization	12
Levels of donor‐derived cell‐free DNA and chemokines in BK polyomavirus‐associated nephropathy	12
Immunosuppression practices during the COVID‐19 pandemic: A multinational survey study of transplant programs	12
Which cava anastomotic techniques are optimal regarding immediate and short‐term outcomes after liver transplantation: A systematic review of the literature and expert panel recommendations	12
The role of preoperative optimization of the nutritional status on the improvement of short‐term outcomes after liver transplantation? A review of the literature and expert panel recommendations	12
Incidence and risk factors of primary non‐function after liver transplantation using grafts from uncontrolled donors after circulatory death	12
Which preoperative assessment modalities best identify patients who are suitable for enhanced recovery after liver transplantation? A systematic review of the literature and expert panel recommendatio	12
Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients	12
User‐centered design features for digital health applications to support physical activity behaviors in solid organ transplant recipients: A qualitative study	12
A retrospective multi‐center experience of renal transplants from India during COVID‐19 pandemic	12

Optimal anesthetic conduct regarding immediate and short‐term outcomes after liver transplantation – Systematic review of the literature and expert panel recommendations	11
Blood product transfusion and lung transplant outcomes: A systematic review	11
Current status and further potential of lung donation after circulatory death	11
Adoption of a novel smart mobile‐health application technology to track chronic immunosuppression adherence in solid organ transplantation: Results of a prospective, observational, multicentre, pilot	11
Cognitive impairment burden in older and younger adults across the kidney transplant care continuum	11
The impact of depression on heart transplant outcomes: A retrospective single‐center cohort study	11
COVID‐19 in heart transplant recipients during February–August 2020: A systematic review	11
Impella 5.5 as a bridge to heart transplantation: Waitlist outcomes in the United States	11
Takotsubo syndrome after liver transplantation: An association with intraoperatively administered epinephrine and fentanyl	11
Availability of PEth testing is associated with reduced eligibility for liver transplant among patients with alcohol‐related liver disease	11
The role of early extubation on short‐term outcomes after liver transplantation – A systematic review, meta‐analysis and expert recommendations	11
The impact of marijuana use on liver transplant recipients: A 900 patient single center experience	11
Longitudinal variance of Donor‐Derived Cell‐Free DNA (dd‐cfDNA) in Stable Kidney Transplant (KTx) patients are influenced by donor/recipient variables	11
Quick preparation of ABO‐incompatible living donor liver transplantation for acute liver failure	11
Telemedicine based remote monitoring after liver transplantation: Feasible in a select group and a more stringent control of immunosuppression	11
Histopathologic findings on indication renal allograft biopsies after recovery from acute COVID‐19	11
Hemophagocytic lymphohistiocytosis occurring after liver transplantation: A case series and review of the literature	11
Textbook surgical outcome in lung transplantation: Analysis of a US national registry	11
Blood transfusion of the donor is associated with stage 3 primary graft dysfunction after lung transplantation	11
Long‐term outcomes of Roux‐en‐Y gastric bypass or sleeve gastrectomy in patients with cirrhosis; before, during or after liver transplantation: A single center's experience	10
Podocyte density is reduced in kidney allografts with high‐risk APOL1 genotypes at transplantation	10
Outcomes of hepatitis C virus nucleic acid testing positive donors in aviremic recipients with delayed direct‐acting antiviral initiation	10
Impact of induction therapy on outcomes after heart transplantation	10
Increased frequency of heart transplantation, shortened waitlist time and preserved post‐transplant survival in adults with congenital heart disease, on the new heart transplant allocation system	10
Geographic disparities in heart transplantation persist under the new allocation policy	10
Surgical complications after living and deceased donor liver transplant: The NSQIP transplant experience	10
The role of acute in‐patient rehabilitation on short‐term outcomes after liver transplantation: A systematic review of the literature and expert panel recommendations	10
Packing the donor heart: Is SherpaPak cold preservation technique safer compared to ice cold storage	10
Lung transplantation from donation after circulatory death, evolution, and current status in the United States	10
Impact of donor smoking history on post heart transplant outcomes: A propensity‐matched analysis of ISHLT registry	10
Induction immunosuppression and the risk of incident malignancies among older and younger kidney transplant recipients: A prospective cohort study	10
Optimal management of perioperative analgesia regarding immediate and short‐term outcomes after liver transplantation – A systematic review, meta‐analysis and expert panel recommendations	10
Perioperative management of living donor liver transplantation: Part 2 – Donors	10
Clinical outcome of kidney transplantation after bariatric surgery: A single‐center, retrospective cohort study	10
Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low‐dose corticosteroids in primary kidney transplantation: 18‐year results	10
A comprehensive review of Strongyloides stercoralis infection after solid organ and hematopoietic stem cell transplantation	10
Optimal surgical workup to ensure safe recovery of the donor after living liver donation – A systematic review of the literature and expert panel recommendations	9
Long‐term outcomes in kidney transplant recipients with end‐stage kidney disease due to anti‐glomerular basement membrane disease	9
Managing the significant drug‐drug interaction between tacrolimus and letermovir in solid organ transplant recipients	9
Impact of COVID‐19 pandemic on the size of US transplant waiting lists	9
Transplantation of liver from hepatitis C–infected donors to hepatitis C RNA–negative recipients: Histological and virologic outcome	9
Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States	9
Impact of the heart transplant allocation policy change on inpatient cost of index hospitalization	9
Exercise‐based rehabilitation strategies in heart transplant recipients: Focus on high‐intensity interval training	9
Size matching in heart transplantation: Is predicted heart mass the optimal method in a United Kingdom cohort?	9
Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conference	9
What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and	9
Primary biliary cholangitis has the highest waitlist mortality in patients with cirrhosis and acute on chronic liver failure awaiting liver transplant	9
Tocilizumab for treatment of chronic active antibody‐mediated rejection in kidney transplant recipients	9
Karnofsky performance status predicts outcomes in candidates for simultaneous liver‐kidney transplant	9
Single‐center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression	9
Post‐transplant inotrope score is associated with clinical outcomes after adult heart transplantation	9
Racial disparities in living donor kidney transplantation in the United States	9
Impact of diabetes mellitus on clinical outcomes after heart transplantation	9
Combining donor derived cell free DNA and gene expression profiling for non‐invasive surveillance after heart transplantation	9
Observed elevated donor‐derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection	9
Avoiding surveillance biopsy: Use of a noninvasive biomarker assay in a real‐life scenario	9
Sweet and simple as syrup: A review and guidance for use of novel antihyperglycemic agents for post‐transplant diabetes mellitus and type 2 diabetes mellitus after kidney transplantation	9
Predictive score for immediate extubation after liver transplantation	9
Liver transplantation for combined hepatocellular‐cholangiocarcinoma: Outcomes and prognostic factors for mortality. A multicenter analysis	8
Outcomes of living‐donor liver transplantation for acute‐on‐chronic liver failure based on newly proposed criteria in Japan	8
The role of graft to recipient weight ratio on enhanced recovery of the recipient after living donor liver transplantation – A systematic review of the literature and expert panel recommendations	8
Lung transplantation outcomes after crossing low‐level donor specific antibodies without planned augmented immunosuppression	8
Changes in waitlist and posttransplant outcomes in patients with adult congenital heart disease after the new heart transplant allocation system	8
Does prolonged cold ischemia affect outcomes in donation after cardiac death donor kidney transplants?	8
Outcomes of kidney donors with pre‐ and post‐donation kidney stones	8
Machine learning‐based prediction of mortality after heart transplantation in adults with congenital heart disease: A UNOS database analysis	8
Acute kidney injury during pregnancy in kidney transplant recipients	8
Incidence, risk factors, and long‐term outcomes associated with antibody‐mediated rejection — The long‐term Deterioration of Kidney Allograft Function (DeKAF) prospective cohort study	8
Successful outcomes with transplanting kidneys from deceased donors with acute kidney injuryon temporary renal replacement therapy	8
An evaluation of the safety and preliminary efficacy of peri‐ and post‐operative treprostinil in preventing ischemia and reperfusion injury in adult orthotopic liver transplant recipients	8
Single‐center utilization of donor‐derived cell‐free DNA testing in the management of heart transplant patients	8
A comparison of cardiopulmonary bypass versus extracorporeal membrane oxygenation: Does intraoperative circulatory support strategy affect outcomes in pediatric lung transplantation?	8
Airway complications in lung transplant recipients with telomere‐related interstitial lung disease	8
Analysis of individual components of frailty: Pre‐transplant grip strength is the strongest predictor of post kidney transplant outcomes	8
One‐year immunologic outcomes of lung transplantation utilizing hepatitis C‐viremic donors	8
Ethical considerations regarding COVID‐19 vaccination for transplant candidates and recipients	8
When is it safe to perform abdominal transplantation in patients with prior SARS‐CoV‐2 infection: A case series	8
Can direct oral anticoagulants be used in kidney transplant recipients?	8
Biomarkers and predictive models of early allograft dysfunction in liver transplantation – A systematic review of the literature, meta‐analysis, and expert panel recommendations	8

Video education to facilitate patient outreach about living kidney donation: A proof of concept	8
The MMDx®diagnostic system: A critical re‐appraisal of its knowledge gaps and a call for rigorous validation studies	8
Pancreas transplantation would be easy if the recipients were not diabetic: A practical guide to post‐operative management of diabetic complications in pancreas transplant recipients	8
Recipient age and outcomes following simultaneous pancreas‐kidney transplantation in the new millennium: Single‐center experience and review of the literature	8
Kidney utilization and outcomes of liver transplant recipients who were listed for kidney after liver transplant after the implementation of safety net policy	8
Transcriptional analysis identifies potential novel biomarkers associated with successful ex‐vivo perfusion of human donor lungs	8
Donor supply for partial heart transplantation in the United States	8
Transplant kidney biopsy for proteinuria with stable creatinine: Findings and outcomes	8
Better outcome of COVID‐19 positive kidney transplant recipients during the unremitting stage with optimized anticoagulation and immunosuppression	8
In kidney recipients from the same deceased donor, discordance in delayed graft function is associated with the worst outcomes	8
First‐day plasma amylase detects patients at risk of complications after simultaneous pancreas‐kidney transplantation	8
Effectiveness and safety of glucagon‐like peptide‐1 receptor agonist in a cohort of kidney transplant recipients	8
“The use of bilateral continuous erector spinae plane blocks for postoperative analgesia after right‐sided living donor hepatectomy: A feasibility study”	8
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation	8
Multimodal opioid‐sparing pain management after lung transplantation and the impact of liposomal bupivacaine intercostal nerve block	8
Cardiac transplantation in adult congenital heart disease with prior sternotomy	8
Comparison of two donor‐derived cell‐free DNA tests and a blood gene‐expression profile test in heart transplantation	8
Identification of cell‐free DNA methylation patterns unique to the human left ventricle as a potential indicator of acute cellular rejection	7
Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis influence suitability for and outcome after living donor liver transplantation? A systematic review o	7
Gastric peroral endoscopic myotomy (GPOEM) for severe gastroparesis after lung transplantation: A promising minimally invasive option	7
De novo tacrolimus extended‐release tablets (LCPT) versus twice‐daily tacrolimus in adult heart transplantation: Results of a single‐center non‐inferiority matched control trial	7
Decreased Nutritional Risk Index is associated with mortality after heart transplantation	7
Utilizing multimodal analgesia to evaluate postoperative analgesic requirements in kidney transplant recipients	7
The Molecular Microscope (MMDXR) interpretation of thoracic and abdominal allograft biopsies: Putting things in perspective for the clinician	7
Marijuana use among adult liver transplant candidates and recipients	7
Designing a patient‐specific search of transplant program performance and outcomes: Feedback from heart transplant candidates and recipients	7
Center variations in patient selection for simultaneous heart‐kidney transplantation	7
Intermediate‐term outcomes of heart transplantation for cardiac amyloidosis in the current era	7
Post‐transplant lymphoproliferative disorder with cutaneous involvement: A series of four cases	7
Bioavailability of once‐daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study	7
Long‐term outcomes of kidney transplantation from deceased donors with terminal acute kidney injury: Single center experience and literature review	7
Financial, policy, and ethical barriers to the expansion of living donor liver transplant: Meeting report from a living donor liver transplant consensus conference	7
Hydroxychloroquine and maintenance immunosuppression use in kidney transplant recipients: Analysis of linked US registry and claims data	7
Early onset of azithromycin to prevent CLAD in lung transplantation: Promising results of a retrospective single centre experience	7
Organ transplant and Covid‐19 vaccination: Considering the ethics of denying transplant to unvaccinated patients	7
Pre‐transplant cognitive screening is a poor predictor of post‐transplant cognitive status	7
Sex mismatch following heart transplantation in the United States: Characteristics and impact on outcomes	7
Kidney utility and futility	7
Pancreas transplantation perceptions and practice: Results from a national US survey	7
Critical interactions between race and the highly granular area deprivation index in liver transplant evaluation	7
NSAID prescriptions in kidney transplant recipients	7
Predictive value of chart‐based frailty evaluation for lung transplant candidates	7
The efficacy of interleukin‐1 antagonist drugs in combination with colchicine in patients with FMF‐AA with colchicine resistance after kidney transplantation: A study with histopathologic evidence	7
Intravascular ultrasound–guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients	7
A systematic review of living kidney donor enhanced recovery after surgery	7
Donor management using a specialized donor care facility is associated with higher organ utilization from drug overdose donors	7
Outcomes of living liver donor candidate evaluations in the Living Donor Collective pilot registry	7
Torquetenovirus viral load is associated with anti‐spike antibody response in SARS‐CoV‐2 mRNA BNT162b2 vaccinated kidney transplant patients	7
The effects of donor‐specific antibody characteristics on cardiac allograft vasculopathy	7
Six‐month risk of Pneumocystis pneumonia following acute cellular rejection: A case‐control study in solid organ transplant recipients	7
Impact of donation after circulatory death heart transplantation on waitlist outcomes and transplantation activity	7
BK virus nephropathy in non‐renal solid organ transplant recipients: Are we looking hard enough?	7
Improved surgical outcomes following simultaneous pancreas‐kidney transplantation in the contemporary era	7
Use of letermovir‐valganciclovir combination as a step‐down treatment after foscarnet for ganciclovir‐resistant CMV infection in kidney transplant recipients	7
Outcomes among CMV‐mismatched and highly sensitized kidney transplants recipients who develop neutropenia	7
Incidence, mortality, and risk factors associated with carbapenem‐resistant Acinetobacter baumannii bacteremia within 30 days after liver transplantation	7
Implementation of patient‐reported outcome measures in a heart transplant recipient registry: First step toward a patient‐centered approach	7
Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference	7
Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients	7
Benefits of both physical assessment and electronic health record review to assess frailty prior to heart transplant	7
Liver transplant after donation from controlled circulatory death versus brain death: A UNOS database analysis and publication bias adjusted meta‐analysis	7
Race does not predict pancreas graft failure after pancreas transplantation in the modern era	7
Treatment of steroid‐refractory chronic graft‐versus‐host disease with imatinib: Real‐life experience of the Spanish group of hematopoietic transplantation (GETH)	7
Trends in organ donation and transplantation over the past eighteen years in Iran	7
Eliminating racial disparities in kidney transplantation	6
Does multimodal perioperative pain management enhance immediate and short‐term outcomes after living donor partial hepatectomy? A systematic review of the literature and expert panel recommendations	6
Association of CMV‐specific T‐cell immunity and risk of CMV infection in lung transplant recipients	6
Association between dd‐cfDNA levels, de novo donor specific antibodies, and eGFR decline: An analysis of the DART cohort	6
Prognostic value of cardiopulmonary exercise test after heart transplantation	6
Current opinions on DGF management practices: A survey of the United States and Canada	6
Does pediatric heart transplant survival differ with various cardiac preservation solutions?	6
Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation	6
The effect of antiplatelet therapy on survival and cardiac allograft vasculopathy following heart transplantation: A systematic review and meta‐analysis	6
Outcome of liver transplantation and prevalence of liver fibrosis in Crigler‐Najjar syndrome	6
Serum Mac‐2 binding protein glycosylation isomer as a biomarker of fibrosis in living donor liver transplant graft	6
COVID‐19 test result reporting for deceased donors: Emergent policies, logistical challenges, and future directions	6
Autoantibodies to LG3 are associated with poor long‐term survival after liver retransplantation	6
The optimal immunosuppression management to prevent early rejection after liver transplantation: A systematic review of the literature and expert panel recommendations	6
Toward telemedicine‐compatible physical functioning assessments in kidney transplant candidates	6
Patient‐reported outcomes after Tixagevimab and Cilgavimab pre‐exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of risk	6
Rabbit anti‐thymocyte globulin administration to treat rejection in simultaneous pancreas and kidney transplant recipients with recent COVID‐19 infection	6
EXPloring attitudes and factors influencing reproductive Choices in kidney Transplant patients (The EXPECT‐study)	6
Tacrolimus time‐in‐therapeutic range is associated with freedom from acute rejection and graft failure following intestinal transplantation	6
Outcome of kidney transplantations from ≥65‐year‐old deceased donors with acute kidney injury	6
Cannulation‐related adverse events of peripheral veno‐arterial extracorporeal membrane oxygenation support in heart transplantation: Axillary versus femoral artery cannulation	6
The volume‐outcomes relationship in donation after circulatory death liver transplantation	6
Impact of SIRPα polymorphism on transplant outcomes in HLA‐identical living donor kidney transplantation	6
Formation of donor‐specific antibodies depends on the epitope load of mismatched HLAs in lung transplant recipients: A retrospective single‐center study	6
Comparing outcomes in right versus left kidney transplantation: A systematic review and meta‐analysis	6
COVID‐19 in heart transplant recipients—A seroprevalence survey	6
Evolving challenges with long‐term care of liver transplant recipients	6
Letermovir for cytomegalovirus prophylaxis in high‐risk heart transplant recipients	6
Impact of the donor hepatectomy time on short‐term outcomes in liver transplantation using donation after circulatory death: A review of the US national registry	6
Less bleeding associated with apixaban versus other direct acting oral anticoagulation in solid organ transplant recipients	6
Use of Continuous Glucose Monitoring for evaluation of hypoglycemia pre‐ and post‐operatively for patients undergoing Total Pancreatectomy with Autologous Islet Cell Transplant	6